What Growth Rate And Market Size Expansion Are Predicted For The Gynecology Surgical Forceps Market Across The Forecast Period?
The gynecology surgical forceps market size has grown strongly in recent years. It will grow from $12.95 billion in 2025 to $13.81 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increase in gynecological surgeries, expansion of hospital infrastructure, rising prevalence of gynecological disorders, growth in women’s healthcare awareness, availability of skilled gynecological surgeons.
The gynecology surgical forceps market size is expected to see strong growth in the next few years. It will grow to $17.44 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growth in minimally invasive gynecological procedures, rising outpatient and day-care surgeries, increasing investments in women’s health services, expansion of ambulatory surgical centers, growing demand for cost-effective surgical instruments. Major trends in the forecast period include growing adoption of minimally invasive gynecological procedures, rising demand for high-precision and ergonomic surgical instruments, increasing preference for reusable and sterilizable forceps, expansion of gynecological surgical volumes in ambulatory settings, rising focus on infection control and surgical safety.
Claim Your Free Report Sample Today:
What Drivers Are Contributing To The Expansion Trajectory Of The Gynecology Surgical Forceps Market?
An increase in the incidence of uterine and vaginal cancer is expected to propel the growth of the gynecology surgical forceps market going forward. Uterine cancer refers to malignancies originating in the uterus, while vaginal cancer pertains to cancers that develop in the vagina, both of which require specialized medical treatment and care. The increase in the incidence of uterine and vaginal cancer is fueled by factors such as aging populations, lifestyle factors such as obesity, which is linked to higher estrogen levels contributing to cancer development. The use of gynecological surgical forceps in uterine and vaginal cancers enhances surgical precision and aids in the effective treatment and management of these conditions, ensuring optimal outcomes for patients undergoing gynecological surgeries. For instance, in January 2023, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, the estimated deaths from uterine cervix cancer in 2022 were 4,280, increasing to 4,310 in 2023, marking a rise of approximately 0.70%. Similarly, deaths from cancers of the vagina and other female genital organs were estimated at 1,630 in 2022 and rose to 1,740 in 2023, representing an increase of about 6.75%. Therefore, an increase in the incidence of uterine and vaginal cancer is driving the gynecology surgical forceps market.
Which Primary Segments Are Included In The Detailed Analysis Of The Gynecology Surgical Forceps Market?
The gynecology surgical forceps market covered in this report is segmented –
1) By Type: Allis Forceps, Artery Forceps, Other Types
2) By Application: Gynecologic Laparoscopic Procedures, Hysteroscopic Procedures, Dilation and Curettage (D&C), Cervical and Uterine Procedures, Gynecologic Biopsy Procedures, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Allis Forceps: Curved Allis Forceps, Straight Allis Forceps, Wide Tip Allis Forceps, Narrow Tip Allis Forceps
2) By Artery Forceps: Kelly Artery Forceps, Crile Artery Forceps, Mosquito Artery Forceps
3) By Other Types: Ring Forceps, Foerster Forceps, Tenaculum Forceps, Uterine Dressing Forceps
What New Trends Are Beginning To Take Shape Within The Gynecology Surgical Forceps Market?
Major companies in the gynecology surgical forceps market are prioritizing innovative product development, including value-driven surgical instruments that offer surgeons reliable quality at accessible prices. For example, in October 2025, gSource, a US-based medical solutions company, launched gSV—a line of more than 260 FDA-registered, ISO 13485-compliant instruments designed to balance high performance with affordability. The collection features both reusable and single-use tools made primarily from German surgical stainless steel and supported by the gSource Lifetime Workmanship Guarantee. This launch underscores the company's commitment to delivering precise, dependable surgical instruments while improving affordability for cost-conscious healthcare professionals.
Which Major Corporations Play A Crucial Role In The Gynecology Surgical Forceps Market Landscape?
Major companies operating in the gynecology surgical forceps market are B. Braun Melsungen AG, Aesculap AG, KLS Martin Group, CooperSurgical Inc., MedGyn Products Inc., Sklar Surgical Instruments, Integra LifeSciences, Teleflex Incorporated, Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Applied Medical Resources Corporation, CONMED Corporation, Smith and Nephew plc, Stryker Corporation, Medline Industries, Hu-Friedy Group, Novo Surgical Inc., Jarit Surgical Instruments, Stainless Surgical India, Surtex Instruments Limited
Get Your In-Depth Gynecology Surgical Forceps Market Report Now:
Which Geographical Region Is Projected To Lead The Gynecology Surgical Forceps Market Throughout The Forecast Period?
North America was the largest region in the gynecology surgical forceps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gynecology surgical forceps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment